as on December 30, 2025 at 2:29 am IST
Day's Low
Day's High
0.07%
Downside
1.07%
Upside
52 Week's Low
52 Week's High
19.79%
Downside
38.23%
Upside
Check Dexcom, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$26.5B
EPS (TTM)
2.065
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
1.10%
PE Ratio (TTM)
37.54
Industry PE ratio
17.123164556962024
PEG Ratio
0.8885
EBITDA
1.0B
Revenue (TTM)
4.5B
Profit Margin
15.96%
Return On Equity TTM
30.64%
Track how Dexcom, Inc. P/E has moved over time to understand its valuation trends.
Dexcom, Inc. in the last 5 years
Lowest (44.21x)
September 30, 2025
Industry (17.12x)
December 29, 2025
Today (37.54x)
December 29, 2025
Highest (175.15x)
September 30, 2021
Today’s Price to Earnings Ratio: 37.54x
Compare market cap, revenue, PE, and other key metrics of Dexcom, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $26.5B | -24.27% | 37.54 | 15.96% | |
| BUY | $142.4B | 170.59% | 51.37 | 14.43% | |
| BUY | $135.5B | 47.07% | 46.49 | 12.07% | |
| BUY | $123.8B | -16.48% | 26.16 | 13.71% | |
| BUY | $51.0B | -3.5% | 38.09 | 23.25% |
The Dexcom, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Dexcom, Inc. investment value today
Current value as on today
₹89,317
Returns
Returns from Dexcom, Inc. Stock
Dollar Returns*
₹5,244 (+5.24%)
Based on 30 analysts
86.67%
Buy
13.33%
Hold
0.00%
Sell
Based on 30 analysts, 86.67% of analysts recommend a 'BUY' rating for Dexcom, Inc.. Average target price of $85.27
Get share price movements and forecasts by analysts on Dexcom, Inc..
What analysts predicted
20.89%UPSIDE
Target Price
$85.27
Current Price
$67.46
Analyzed by
30 Analysts
Target
$85.27
Dexcom, Inc. target price $85.27, a slight upside of 20.89% compared to current price of $67.46. According to 30 analysts rating.
Search interest for Dexcom, Inc. Stock has decreased by -62% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 22 December
Mon, 07:12 PM
-DexCom receives FDA clearance for Smart Basal, enhancing insulin management for Type 2 diabetes patients.
Mon, 08:30 PM
-DexCom's rating is 69% based on fundamentals; a score above 80% indicates strong interest.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Dexcom, Inc. has shown strong profit growth over the last three quarters. The company's net profit increased from $105.4 million to $283.8 million, which reflects an average growth of 39.0% each quarter.
Revenue Rich
![]()
Dexcom, Inc. has shown positive revenue growth over the last three quarters. Revenue increased from $1.03 billion to $1.20 billion, reflecting an average increase of 7.4% per quarter.
Price Rise
![]()
In the last 1 month, DXCM stock has moved up by 6.5%
Against Peers
![]()
In the last 1 year, Medtronic Plc has given 19.5% return, outperforming this stock by 35.3%
Against Peers
![]()
In the last 3 years, Boston Scientific Corp. has given 24.0% return, outperforming this stock by 63.7%
| Organisation | Dexcom, Inc. |
| Headquarters | 6340 Sequence Drive, San Diego, CA, United States, 92121 |
| Industry | Health Technology |
| CEO | Mr. Jacob Steven Leach |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Michael Jon Brown | Executive VP & Chief Legal Officer |
Mr. Girish Naganathan | Executive VP & CTO |
Mr. Sean Christensen | Vice President of Finance and Investor Relations |
Mr. Matthew Dolan | Executive Vice President of Strategy & Corporate Development |
Mr. Donald M. Abbey | Executive Vice President of Global Business Services, IT, Quality & Regulatory Affairs |
Mr. Jacob Steven Leach | Interim CEO, President & COO |
Mr. Jereme M. Sylvain CPA | Executive VP, CFO & Chief Accounting Officer |
Mr. Jon Coleman | Executive VP & Chief Commercial Officer |
Mr. Kevin Ronald Sayer | Executive Chairman & CEO (Leave of Absence) |
Ms. Sadie M. Stern | Executive VP & Chief Human Resources Officer |
Dexcom, Inc. share price today is $67.46 as on at the close of the market. Dexcom, Inc. share today touched a day high of $68.18 and a low of $67.41.
Dexcom, Inc. share touched a 52 week high of $93.25 on and a 52 week low of $54.11 on . Dexcom, Inc. stock price today i.e. is closed at $67.46,which is 27.66% down from its 52 week high and 24.67% up from its 52 week low.
Dexcom, Inc. market capitalisation is $0.03T as on .
Indian investors can start investing in Dexcom, Inc. (DXCM) shares with as little as ₹89.985 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹899.85 in Dexcom, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Dexcom, Inc. share’s latest price of $67.46 as on December 30, 2025 at 2:29 am IST, you will get 0.1482 shares of Dexcom, Inc.. Learn more about
fractional shares .
Dexcom, Inc. stock has given -24.27% share price returns and 22.33% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?